
Please contact the doctor's office to verify that your insurance is accepted.
Dr. Jennifer Claytor specializes in the care of patients with inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, and in the care of patients facing immune-mediated complications of cancer therapy, including GI graft-versus-host disease (GVHD) and immune checkpoint inhibitor enterocolitis. She is an assistant professor of medicine and member of the Jill Roberts Center for IBD at Weill Cornell Medicine.
Dr. Claytor graduated from Yale University with a B.A. in Literature and received an M.S. in Narrative Medicine from Columbia University. She attended medical school at the University of North Carolina, Chapel Hill, where she was elected to the alph...
IBD Biomarkers: Established Tests Are Helpful but Clinicians Want More
REG3α is a Predictive Biomarker of Complicated Disease from Preclinical through Established Crohn's Disease.
Statin Use is Associated With Lower Odds of IBD-Related Surgery Among Patients With Moderate-to-Severe Inflammatory Bowel Disease.
Pseudo-Pseudo Polyp: Spindle Cell Sarcoma at an Ileocolonic Anastomosis.